EDITOR,-There is now increasing evidence that most children with recurrent wheeze in the first year of life do not have atopic asthma and that 'wheezy bronchitis' is a distinct entity with a different natural history.' Although it is now clear that infants are able to respond to bronchodilators, it is well known that j3 agonists are rarely effective in this age group during wheezing episodes. Despite this, it is still widely believed that bronchospasm is the main cause of wheeze in these children. (1) In the audit 62 cases were detected out of 228 289 livebirths over a period of seven vears, giving a birth prevalence of 1:3682 and not 1:3770 as stated in the article.
(2) If the 95% confidence intervals for the data presented were to be worked out it would give the possible range of birth prevalence as 1:2872 to 1:4803 (using the Poission distribution). This means, that for 228 289 livebirths, the region could have had between 48 and 79 cases of congenital hypothyroidism. Taking the upper limit would imply that the programme could have missed up to 19 cases -that is, two false negatives that this audit picked up and 17 others that were not.
(3) An examination of the data from European countries mentioned in the statement above showed that 14 European countries (73 centres) had a collective birth prevalence of 1:3598 but there was intercountry variation from 1:2860 in the Netherlands to 1:5770 in Austria.2 There is nothing to suggest that the
